Teva Pharmaceutical Industries Ltd. (TEVA)

7.45
0.08 1.06
NYSE : Health Technology
Prev Close 7.53
Open 7.57
Day Low/High 7.38 / 7.70
52 Wk Low/High 6.07 / 25.00
Volume 17.95M
Avg Volume 20.66M
Exchange NYSE
Shares Outstanding 1.09B
Market Cap 8.58B
EPS -2.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Teva Announces United States Department Of Commerce Appointment Of Brendan O'Grady To Investment Advisory Council

Teva Announces United States Department Of Commerce Appointment Of Brendan O'Grady To Investment Advisory Council

Teva Pharmaceutical Industries (NYSE and TASE: TEVA) today announced that the U.

Teva To Present New Analyses Of Fremanezumab Efficacy And Safety In Adult Patients With Difficult-to-Treat Migraine At 19th Congress Of The International Headache Society

Teva To Present New Analyses Of Fremanezumab Efficacy And Safety In Adult Patients With Difficult-to-Treat Migraine At 19th Congress Of The International Headache Society

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the Company will present more than 30 analyses on fremanezumab, at the 19 th Congress of the International Headache Society (IHC), taking place in Dublin, Ireland on September 5-8,...

These Drug Cos. Could Soon Feel Big Side Effects of Opioid Crisis

These Drug Cos. Could Soon Feel Big Side Effects of Opioid Crisis

No company is safe from the litigation risk tied to the drug epidemic, but Johnson & Johnson may be one of the few guaranteed to survive.

Johnson & Johnson Rises on $572 Million Fine That's Smaller Than Feared

Johnson & Johnson Rises on $572 Million Fine That's Smaller Than Feared

Wall Street expects the healthcare giant can take the jolt from the penalty delivered by an Oklahoma judge in the state's opioid case against J&J.

Dow Futures, Johnson & Johnson, Boeing, Papa John's - 5 Things You Must Know

Dow Futures, Johnson & Johnson, Boeing, Papa John's - 5 Things You Must Know

U.S. stock futures rise modestly on Tuesday as investors are cautiously optimistic a trade deal between Washington and Beijing can be reached; Johnson & Johnson is found responsible for helping fuel the opioid crisis in Oklahome and is ordered to pay $572 million; Russian conglomerate Rostec confirms it filed a lawsuit in the United States to cancel its order for Boeing 737 MAX jets, a report says.

Union Pacific, Pfizer, Merck, AbbVie: 'Mad Money' Lightning Round

Union Pacific, Pfizer, Merck, AbbVie: 'Mad Money' Lightning Round

Jim Cramer takes a look at Union Pacific, Pfizer, Merck, AbbVie, Teva Pharmaceuticals, ABM Industries, Schlumberger and more.

Hear Now the News (and Updates) on 2 Key Positions

Antares Pharma and Encana are on our radar today.

Teva Rises on Positive Test Results for Migraine Treatment

Teva Rises on Positive Test Results for Migraine Treatment

Teva says patients taking Ajovy experienced a significant reduction in migraine days compared to those receiving placebos.

Fremanezumab Data In The Lancet Demonstrate Clinically Meaningful Reduction In Monthly Migraine Days Versus Placebo For Patients With Difficult-To-Treat Migraine

Fremanezumab Data In The Lancet Demonstrate Clinically Meaningful Reduction In Monthly Migraine Days Versus Placebo For Patients With Difficult-To-Treat Migraine

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that results from the Phase IIIb FOCUS study, which examined fremanezumab versus placebo in adult migraine patients who previously experienced inadequate responses to two to four...

Endo Surges as Opioid Maker Reaches Settlement in Landmark Lawsuit

Endo Surges as Opioid Maker Reaches Settlement in Landmark Lawsuit

Endo's stock price surges after the company announces a settlement with Cuyahoga and Summit counties, removing the company from a potentially damaging trial in state court in October.

SHAREHOLDER ALERT - Teva Pharmaceutical Industries Ltd. (TEVA) - Bronstein, Gewirtz & Grossman, LLC Alerts Stockholders Of Class Action And Lead Plaintiff Deadline: August 20, 2019

SHAREHOLDER ALERT - Teva Pharmaceutical Industries Ltd. (TEVA) - Bronstein, Gewirtz & Grossman, LLC Alerts Stockholders Of Class Action And Lead Plaintiff Deadline: August 20, 2019

NEW YORK, Aug. 20, 2019 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Teva Pharmaceutical Industries Ltd.

Teva's Generic EpiPen Jr Is Now Available for $300

Teva's Generic EpiPen Jr Is Now Available for $300

There has been an EpiPen shortage in the U.S., Europe and Canada, thanks to manufacturing delays at Pfizer.

Teva Announces Availability Of A Generic Equivalent Of EpiPen Jr® (epinephrine Injection, USP) Auto-Injector, 0.15 Mg In The United States

Teva Announces Availability Of A Generic Equivalent Of EpiPen Jr® (epinephrine Injection, USP) Auto-Injector, 0.15 Mg In The United States

Teva Pharmaceutical Industries (NYSE and TASE: TEVA) today announced availability of the FDA-approved generic version of EpiPen Jr® 1 (epinephrine injection, USP) Auto-Injector, 0.

Endo, Allergan Nearing Deals to Limit Ohio Litigation Over Opioids - Report

Endo, Allergan Nearing Deals to Limit Ohio Litigation Over Opioids - Report

Allergan is said to be discussing paying $5 million while Endo is close to an agreement to pay $10 million, according to a report.

How to Extract Pretty Profits from Ugly Stocks

How to Extract Pretty Profits from Ugly Stocks

It's a process that involves harvesting gains by repeatedly writing call options against stocks steadily in decline.

Stocks Finish Mixed in Volatile Trading Day

Stocks Finish Mixed in Volatile Trading Day

Stocks fell sharply before ending mixed Wednesday, as investors grappled with the U.S.-China trade war.

Teva Tops Q2 Earnings Forecast, Holds 2019 Guidance; CFO Departure Hits Shares

Teva Tops Q2 Earnings Forecast, Holds 2019 Guidance; CFO Departure Hits Shares

Teva Pharmaceutical posted stronger-than-expected second quarter earnings Wednesday, and reiterated its full-year profit guidance, as new generic drug launches in north America boosted revenue growth.

China's Yuan Threat, Disney Volatility: Market Recon

China's Yuan Threat, Disney Volatility: Market Recon

The Chinese government has now demonstrated an ability to control the S&P 500, even at the risk of Chinese domestic capital flight.

Disney, CVS, Lyft, Walgreens and Tesla - 5 Things You Must Know

Disney, CVS, Lyft, Walgreens and Tesla - 5 Things You Must Know

U.S. stock futures rise Wednesday but trading is cautious amid concerns the U.S.-China trade dispute could spiral into a currency war; Disney's fiscal third-quarter earnings and revenue miss analysts' expectations; CVS Health and Lyft to report earnings.

Teva Announces CFO Leadership Transition

Teva Announces CFO Leadership Transition

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Michael (Mike) McClellan, Executive Vice President and Chief Financial Officer ("CFO"), has decided to step down from his role as CFO due to personal reasons requiring him to...

Teva Reports Second Quarter 2019 Financial Results

Teva Reports Second Quarter 2019 Financial Results

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA, TASE: TEVA) today reported results for the quarter ended June 30, 2019.

Big Pharma Sees Pockets of Recent Insider Buying

Big Pharma Sees Pockets of Recent Insider Buying

AbbVie and Bristol-Myers Squibb are two pharmaceutical giants where insiders have snatched up big blocks of stock.

Disney, Uber, Lyft and More - Earnings to Watch in the Week Ahead

Disney, Uber, Lyft and More - Earnings to Watch in the Week Ahead

While you may think earnings season is winding down, we still got quite a bit left to go ... here are key companies to keep an eye on the week of August 5, 2019.

Teva Shares Slump on Opioid Litigation Risk Downgrade From Morgan Stanley

Teva Shares Slump on Opioid Litigation Risk Downgrade From Morgan Stanley

Shares of Teva Pharmaceuticals fall after the company receives a downgrade from Morgan Stanley amid heightened "litigation risks" related to its involvement in the opioid crisis.

Teva Announces FDA Approval Of AirDuo® Digihaler™ (fluticasone Propionate 113 Mcg And Salmeterol 14 Mcg) Inhalation Powder

Teva Announces FDA Approval Of AirDuo® Digihaler™ (fluticasone Propionate 113 Mcg And Salmeterol 14 Mcg) Inhalation Powder

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the U.

Before You Sell Like the Insiders, Take a Hard Look at the Charts

Studying the indicators shows we’re overbought and still complacent, but still some charts deserve special focus, like insider selling, the McClellan Summation Index and small caps.

Teva Completes Facilities Purchase In Pennsylvania For North America Research & Development Campus

Teva Completes Facilities Purchase In Pennsylvania For North America Research & Development Campus

Teva Pharmaceuticals USA, Inc. today announced that the company has completed the purchase of three buildings on Brandywine Parkway in West Chester, Pa.

TheStreet Quant Rating: D (Sell)